CV Risk Reduction Requires Much More than Statins

ANAHEIM, CA—Statins will only go so far in reducing the incidence of cardiovascular events, said H. Robert Superko, MD, at Nutracon, an annual conference on advances in nutraceutical product development.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.
Subscribe to Holistic Primary Care